URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Kevin Biglan

TitleAssociate Professor
InstitutionSchool of Medicine and Dentistry
DepartmentNeurology
Address
 
 Awards And Honors
      1988-1992 Walton Academic Scholar, Scholarship awarded to the top 10% of matriculating students 1991, 1992 Deans Achievement Award, Award given to junior and senior students for academic excellence 1992 Cyrus E. Beekey Memorial Award, Award to a graduating senior for excellence in biology. 1996 Arthur Krieger Memorial Prize in Neurology, Award to the senior medical student exhibiting excellence in neurology 2000 Alpha Omega Alpha, Medical honor society. 2000 American Academy of Neurology Resident Scholarship, Scholarship awarded to residents exhibiting dedication to teaching 2002,2004 NIH Clinical Research Loan Repayment Award, A competitive award for clinical researchers wishing to pursue a career in academic medicine
 
 Selected Publications
List All   |   Timeline
  1. Dorsey ER, Venkataraman V, Grana MJ, Bull MT, George BP, Boyd CM, Beck CA, Rajan B, Seidmann A, Biglan KM. Randomized controlled clinical trial of "virtual house calls" for Parkinson disease. JAMA Neurol. 2013 May 1; 70(5):565-70.
    View in: PubMed
  2. Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, Shoulson I. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 2013 May 28; 80(22):2022-7.
    View in: PubMed
  3. McGarry A, Biglan K. Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and parkinsonism. Parkinsonism Relat Disord. 2013 Jun; 19(6):643-4.
    View in: PubMed
  4. Biglan KM, Zhang Y, Long JD, Geschwind M, Kang GA, Killoran A, Lu W, McCusker E, Mills JA, Raymond LA, Testa C, Wojcieszek J, Paulsen JS. Refining the diagnosis of Huntington disease: the PREDICT-HD study. Front Aging Neurosci. 2013; 5:12.
    View in: PubMed
  5. Killoran A, Biglan KM. 8-OHdG: its (limited) potential as a biomarker for Huntington's disease. Biomark Med. 2012 Dec; 6(6):777-80.
    View in: PubMed
  6. Abdolahi A, Scoglio N, Killoran A, Dorsey ER, Biglan KM. Potential reliability and validity of a modified version of the Unified Parkinson's Disease Rating Scale that could be administered remotely. Parkinsonism Relat Disord. 2013 Feb; 19(2):218-21.
    View in: PubMed
  7. George BP, Scoglio NJ, Reminick JI, Rajan B, Beck CA, Seidmann A, Biglan KM, Dorsey ER. Telemedicine in Leading US Neurology Departments. Neurohospitalist. 2012 Oct; 2(4):123-8.
    View in: PubMed
  8. Grana MJ, Bull MT, Venkataraman V, Dorsey ER, Biglan KM. Web-based clinical assessments for Parkinson's disease: reliable and feasible. Mov Disord. 2012 Sep 15; 27(11):1466.
    View in: PubMed
  9. Shprecher D, Noyes K, Biglan K, Wang D, Dorsey ER, Kurlan R, Adams MJ. Willingness of Parkinson's disease patients to participate in research using internet-based technology. Telemed J E Health. 2012 Nov; 18(9):684-7.
    View in: PubMed
  10. Unschuld PG, Joel SE, Liu X, Shanahan M, Margolis RL, Biglan KM, Bassett SS, Schretlen DJ, Redgrave GW, van Zijl PC, Pekar JJ, Ross CA. Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease. Neurosci Lett. 2012 Apr 18; 514(2):204-9.
    View in: PubMed
  11. Dorsey R, Biglan K, Eberly S, Auinger P, Brocht A, Umeh CC, Oakes D, Clarence-Smith K, Marshall F, Shoulson I, Frank S. Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study. PLoS Curr. 2011; 3:RRN1283.
    View in: PubMed
  12. Vaccarino AL, Sills T, Anderson KE, Biglan K, Borowsky B, Giuliano J, Guttman M, Ho AK, Kennard C, Kupchak P, Landwehrmeyer GB, Michell A, Paulsen JS, Reilmann R, van Kammen DP, Warner JH, Evans K. Assessment of motor symptoms and functional impact in prodromal and early huntington disease. PLoS Curr. 2011; 2:RRN1244.
    View in: PubMed
  13. Dorsey ER, Deuel LM, Beck CA, Gardiner IF, Scoglio NJ, Scott JC, Marshall FJ, Biglan KM. Group patient visits for Parkinson disease: a randomized feasibility trial. Neurology. 2011 May 3; 76(18):1542-7.
    View in: PubMed
  14. Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH. Neurocognitive signs in prodromal Huntington disease. Neuropsychology. 2011 Jan; 25(1):1-14.
    View in: PubMed
  15. Biglan KM. Tapping in Huntington disease: a path forward to preventive therapies? Neurology. 2010 Dec 14; 75(24):2142-3.
    View in: PubMed
  16. Deuel LM, Chesire AM, Eason S, Como PG, Biglan KM. Reply: An exploration of the burden experienced by spousal caregivers of individuals with Parkinson's disease. Mov Disord. 2010 Oct 15; 25(13):2254-5.
    View in: PubMed
  17. Dorsey ER, Voss TS, Shprecher DR, Deuel LM, Beck CA, Gardiner IF, Coles MA, Burns RS, Marshall FJ, Biglan KM. A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups. Mov Disord. 2010 Oct 15; 25(13):2128-35.
    View in: PubMed
  18. Abhinav K, Marsh L, Crain B, Reich SG, Biglan K. Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature. Neurol Sci. 2011 Feb; 32(1):159-63.
    View in: PubMed
  19. Dorsey ER, Deuel LM, Voss TS, Finnigan K, George BP, Eason S, Miller D, Reminick JI, Appler A, Polanowicz J, Viti L, Smith S, Joseph A, Biglan KM. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov Disord. 2010 Aug 15; 25(11):1652-9.
    View in: PubMed
  20. Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS. Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov Disord. 2009 Sep 15; 24(12):1763-72.
    View in: PubMed
  21. Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Arch Neurol. 2009 Sep; 66(9):1099-104.
    View in: PubMed
  22. Biglan KM, Voss TS, Deuel LM, Miller D, Eason S, Fagnano M, George BP, Appler A, Polanowicz J, Viti L, Smith S, Joseph A, Dorsey ER. Telemedicine for the care of nursing home residents with Parkinson's disease. Mov Disord. 2009 May 15; 24(7):1073-6.
    View in: PubMed
  23. Marsh L, Biglan K, Gerstenhaber M, Williams JR. Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord. 2009 Jan 30; 24(2):277-82.
    View in: PubMed
  24. Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP. The relationship between CAG repeat length and clinical progression in Huntington's disease. Mov Disord. 2008 Jul 15; 23(9):1223-7.
    View in: PubMed
  25. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry. 2008 Aug; 79(8):874-80.
    View in: PubMed
  26. Biglan KM, Holloway RG, McDermott MP, Richard IH. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology. 2007 Jul 10; 69(2):187-95.
    View in: PubMed
  27. Frank S, Biglan K. Long-term fetal cell transplant in Huntington disease: stayin' alive. Neurology. 2007 Jun 12; 68(24):2055-6.
    View in: PubMed
  28. Biglan K, Shoulson I. Juvenile-onset huntington disease: a matter of perspective. Arch Neurol. 2007 Jun; 64(6):783-4.
    View in: PubMed
  29. Biglan KM, Ravina B. Neuroprotection in Parkinson's disease: an elusive goal. Semin Neurol. 2007 Apr; 27(2):106-12.
    View in: PubMed
  30. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007 Jan 30; 68(5):384-6.
    View in: PubMed
  31. Biglan KM, Halmagyi M. The eyes as a window into disease prevention. Neurology. 2006 Aug 8; 67(3):376-7.
    View in: PubMed
  32. Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Mov Disord. 2006 May; 21(5):616-23.
    View in: PubMed
  33. Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53.
    View in: PubMed
  34. Biglan KM, Holloway RG. Surrogate endpoints in Parkinson's disease research. Curr Neurol Neurosci Rep. 2003 Jul; 3(4):314-20.
    View in: PubMed
  35. Young WB, Piovesan EJ, Biglan KM. Restless legs syndrome and drug-induced akathisia in headache patients. CNS Spectr. 2003 Jun; 8(6):450-6.
    View in: PubMed
  36. Biglan KM, Holloway RG. A review of pramipexole and its clinical utility in Parkinson's disease. Expert Opin Pharmacother. 2002 Feb; 3(2):197-210.
    View in: PubMed
  37. Biglan K, Holloway RG. Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials. Curr Neurol Neurosci Rep. 2001 Jul; 1(4):329-36.
    View in: PubMed

Visualizations


Biglan's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department